Greg Martin
Chief Financial Officer
Replay available
Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2026 Earnings Call
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Tom McCourt
Chief Executive Officer
Tammy Gaskins
Chief Commercial Officer
Mike Schatzlein
Chief Medical Officer
Mohit Bensal
Analyst, Wells Fargo
Jason Butler
Analyst, Citizens GMT
Chase Knickerbocker
Analyst, Craig Collin
Tom Rosenthal
Analyst, InGen Health Research
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ironwood Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.010 -- 00:00:04.774 Thank you for standing by. My name is Liz and I'll be your conference operator today. 00:00:04.774 -- 00:00:09.959 At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals first 00:00:09.959 -- 00:00:12.341 quarter 2026 investor 00:00:12.341 -- 00:00:16.986 update conference call. All lines have been placed on mute to prevent any background 00:00:16.986 -- 00:00:21.551 noise. After the speaker's remarks, there will be a question and answer session. 00:00:21.551 -- 00:00:25.855 If you would like to ask a question during this time, simply press star followed by the 00:00:25.855 -- 00:00:30.119 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:30.119 -- 00:00:34.918 star one again. Thank you. I would now like to turn the call over to Greg Martin, Chief 00:00:34.918 -- 00:00:38.982 Financial Officer. Please go ahead. 00:00:39.185 -- 00:00:44.634 Good morning, and thank you for joining us for our first quarter 2026 investor update. 00:00:44.634 -- 00:00:48.681 Our press release issued this morning can be found on our website. 00:00:48.681 -- 00:00:53.269 Today's call and accompanying slides include forward-looking statements within the meaning 00:00:53.269 -- 00:00:57.794 of the Private Securities Litigation Reform Act of 1995. 00:00:57.794 -- 00:01:03.680 Such statements involve risk certainties that may cause actual results to differ materially. 00:01:03.680 -- 00:01:07.523 The discussion of these statements and risk factors is available on the current Safe 00:01:07.523 -- 00:01:12.668 Harbor Statement slide, as well as under the heading Risk Factors in our annual report 00:01:12.668 -- 00:01:17.431 on Form 10-K for the year ended December 31st, 2025, 00:01:17.453 -- 00...